Travere Therapeutics Inc Working Capital to Net Assets Ratio
Travere Therapeutics Inc working capital to net assets ratio. Travere Therapeutics Inc (TVTX) has a Working Capital to Net Assets ratio of 1888.6% as of June 2026. Working capital of $463.12 Million (current assets of $615.14 Million minus current liabilities of $152.03 Million) is measured against net assets of $24.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Travere Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Travere Therapeutics Inc (2010–2025)
Working capital to net assets ratio of Travere Therapeutics Inc from 2010 to 2025. This chart shows how Travere Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of June 2026, the ratio stands at 1888.6%, reflecting working capital of $463.12 Million against net assets of $24.52 Million USD. See TVTX defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Travere Therapeutics Inc Working Capital to Net Assets Ratio by Year (2010–2025)
Travere Therapeutics Inc working capital to net assets ratio by year from 2010 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Travere Therapeutics Inc from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Travere Therapeutics Inc (TVTX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 241.8% | $277.66 Million | $114.83 Million | $437.56 Million | $159.90 Million | ▼ -123.7 pp |
| 2024 | 365.5% | $215.95 Million | $59.08 Million | $416.70 Million | $200.75 Million | ▲ +147.0 pp |
| 2023 | 218.5% | $438.87 Million | $200.81 Million | $616.77 Million | $177.91 Million | ▼ -584.9 pp |
| 2022 | 803.4% | $344.27 Million | $42.85 Million | $486.44 Million | $142.16 Million | ▲ +651.6 pp |
| 2021 | 151.8% | $458.74 Million | $302.11 Million | $582.83 Million | $124.09 Million | ▲ +1.4 pp |
| 2020 | 150.4% | $317.75 Million | $211.21 Million | $410.41 Million | $92.66 Million | ▼ -0.4 pp |
| 2019 | 150.8% | $333.62 Million | $221.20 Million | $429.06 Million | $95.45 Million | ▲ +27.9 pp |
| 2018 | 122.9% | $391.06 Million | $318.25 Million | $495.68 Million | $104.62 Million | ▲ +41.0 pp |
| 2017 | 81.9% | $240.14 Million | $293.13 Million | $325.81 Million | $85.67 Million | ▲ +1.0 pp |
| 2016 | 80.9% | $249.09 Million | $307.77 Million | $332.35 Million | $83.26 Million | ▲ +8.9 pp |
| 2015 | 72.1% | $216.13 Million | $299.97 Million | $301.93 Million | $85.80 Million | ▼ -116.4 pp |
| 2014 | 188.5% | $-70.20 Million | $-37.25 Million | $37.33 Million | $107.54 Million | ▲ +37.2 pp |
| 2013 | 151.3% | $-27.71 Million | $-18.31 Million | $7.50 Million | $35.21 Million | ▼ -17.9 pp |
| 2012 | 169.2% | $-5.77 Million | $-3.41 Million | $33.22K | $5.80 Million | ▲ +69.2 pp |
| 2011 | 100.0% | $-63.08K | $-63.08K | $3.91K | $66.99K | ▲ +0.0 pp |
| 2010 | 100.0% | $-60.26K | $-60.26K | $3.96K | $64.21K | — |